CAR-T therapy shows promise against tough leukemia in real patients
NCT ID NCT07269587
Summary
This study looks back at how well CNCT-19 CAR-T cell therapy worked for 275 Chinese adults with B-cell acute lymphoblastic leukemia. Researchers are checking how many patients responded to treatment, how long remissions lasted, and what side effects occurred. The goal is to understand how this advanced therapy performs in real-world hospital settings outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAR T-CELL THERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Conditions
Explore the condition pages connected to this study.